User profiles for Jaya Chandrasekhar

Jaya Chandrasekhar

Eastern Health, Melbourne, Australia
Verified email at monash.edu
Cited by 2672

Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014

J Chandrasekhar, G Dangas, J Yu… - Journal of the American …, 2016 - jacc.org
Background : A differential impact of sex has been observed in transcatheter aortic valve
replacement (TAVR) outcomes from small observational studies and subgroup analyses of …

Acute myocardial infarction in young women: current perspectives

J Chandrasekhar, A Gill, R Mehran - International journal of …, 2018 - Taylor & Francis
Acute myocardial infarction (AMI) is the leading cause of death in women worldwide. Every
year, in the USA alone, more than 30,000 young women <55 years of age are hospitalized …

Sex‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention …

J Chandrasekhar, U Baber, S Sartori… - Catheterization and …, 2017 - Wiley Online Library
Background Young women undergoing percutaneous coronary intervention (PCI) for acute
coronary syndrome (ACS) experience greater adverse events than men, potentially due to …

Sex-based differences in acute coronary syndromes: insights from invasive and noninvasive coronary technologies

J Chandrasekhar, R Mehran - JACC: Cardiovascular Imaging, 2016 - jacc.org
Acute coronary syndromes (ACS) may result from atherosclerotic or nonatherosclerotic
mechanisms, and commonly but not always present as plaque rupture. Women presenting with …

Sex disparities in cardiovascular device evaluations: strategies for recruitment and retention of female patients in clinical device trials

MI Ghare, J Chandrasekhar, R Mehran, V Ng… - Cardiovascular …, 2019 - jacc.org
Women have historically been underrepresented in clinical trials evaluating cardiovascular
devices. Existing initiatives through government agencies have made some progress, but …

Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER …

W Vlastra, J Chandrasekhar… - European heart …, 2019 - academic.oup.com
Aims The aim of this study was to compare clinical outcomes of patients undergoing transfemoral
transcatheter aortic valve implantation (TAVI) with balloon-expandable (BE) valves vs. …

Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: rationale and design of the TWILIGHT study

…, PG Steg, J Badimon, MU Zafar, J Chandrasekhar… - American heart …, 2016 - Elsevier
Background Dual antiplatelet therapy (DAPT) is necessary to prevent thrombosis yet
increases bleeding after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). …

Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI

AD Hosseiny, S Moloi, J Chandrasekhar, A Farshid - Open heart, 2016 - openheart.bmj.com
Objective We aimed to assess the pattern of mortality and cause of death in a cohort of
patients with ST-segment elevation myocardial infarction (STEMI) treated with primary …

Transfemoral vs non-transfemoral access for transcatheter aortic valve implantation: a systematic review and meta-analysis

J Chandrasekhar, B Hibbert, M Ruel, BK Lam… - Canadian Journal of …, 2015 - Elsevier
Background Transcatheter aortic valve implantation (TAVI) is the definitive therapy for high-risk
patients with severe aortic stenosis. The aim of this study was to determine the effect of …

Predictors, incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke: from the CENTER …

…, D Tchétché, J Chandrasekhar… - Circulation …, 2019 - Am Heart Assoc
Background: Stroke remains one of the most devastating complications of transcatheter
aortic valve implantation (TAVI). The aim of this study was to identify the incidence, timing, …